Ausgabe 1/2023
Inhalt (47 Artikel)
Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival
Christine Auberle, Daniel Lenihan, Feng Gao, Amanda Cashen
Left atrial appendage volume as a prognostic Indicator of long-term mortality in Cancer survivors treated with thoracic radiation
Meer R. Zafar, Ashutosh Sharma, Sunitha Shyam Sunder, Badri Karthikeyan, Makoto Nagahama, Andrew Atia, Ronak Bahuva, Saraswati Pokharel, Vijay Iyer, Sharma Kattel, Umesh C. Sharma
Cardiac hemangioma presenting as a primary cardiac tumor
Leart Berdica, Erisa Kola, Daniela Nakuci, Edlira Horjeti, Mehdi Alimehmeti
Reversible cardiomyopathy in a patient with chronic myelomonocytic leukemia treated with decitabine/cedazuridine: a case report
Ankur Sheel, Junu Bae, Ashlee Asada, Gregory A. Otterson, Ragavendra R. Baliga, Kristin L. Koenig
Functional testing, coronary artery calcifications, and outcomes in Hodgkin lymphoma survivors treated with chest radiation
Sanjay Divakaran, Diana M. Lopez, Sean M. Parks, Jon Hainer, Andrea K. Ng, Ron Blankstein, Marcelo F. Di Carli, Anju Nohria
Malignant cancer may increase the risk of all-cause in-hospital mortality in patients with acute myocardial infarction: a multicenter retrospective study of two large public databases
Jianfeng Ye, Luming Zhang, Jun Lyu, Yidan Wang, Shiqi Yuan, Zhifeng Qin, Yu Liu, Tao Huang, Jinwei Tian, Haiyan Yin
Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design
Sherry-Ann Brown, Brian Y. Chung, Krishna Doshi, Abdulaziz Hamid, Erin Pederson, Ragasnehith Maddula, Allen Hanna, Indrajit Choudhuri, Rodney Sparapani, Mehri Bagheri Mohamadi Pour, Jun Zhang, Anai N. Kothari, Patrick Collier, Pedro Caraballo, Peter Noseworthy, Adelaide Arruda-Olson
Cancer incidence and mortality in patients diagnosed with heart failure: results from an updated systematic review and meta-analysis
Massimiliano Camilli, Juan Guido Chiabrando, Marco Lombardi, Marco Giuseppe Del Buono, Rocco Antonio Montone, Antonella Lombardo, Filippo Crea, Giorgio Minotti
Enzalutamide induced non-ischemic cardiomyopathy. A case report and review of literature on anti-androgen therapy-related cardiovascular events
Aswini Kumar, Aswanth Reddy, Arjun Sekar
Efficacy and safety of cardioprotective drugs in chemotherapy-induced cardiotoxicity: an updated systematic review & network meta-analysis
Ali Mir, Yasra Badi, Seif Bugazia, Anas Zakarya Nourelden, Ahmed Hashem Fathallah, Khaled Mohamed Ragab, Mohammed Alsillak, Sarah Makram Elsayed, Abdulrahman Ibrahim Hagrass, Sawyer Bawek, Mohamad Kalot, Zachary L. Brumberger
Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study
Tomohiro Kaneko, Sakiko Miyazaki, Azusa Kurita, Ryoko Morimoto, Shun Tsuchiya, Naoki Watanabe, Tomoiku Takaku, Norio Komatsu, Tohru Minamino
The association of preoperative high-sensitivity cardiac troponin i and long-term outcomes in colorectal cancer patients received tumor resection surgery
Yitao Zhang, Zicheng Huang, Sutian Hu, Jinhong Si, Shiyao Cheng, Zhichong Chen, Jiaojie Xue, Xue Lou, Huajing Peng, Zequan Li, Mao Ouyang, Xiang Gao, Weijie Zeng
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy
Anthony F. Yu, Chau T. Dang, Justine Jorgensen, Chaya S. Moskowitz, Patricia DeFusco, Eric Oligino, Kevin C. Oeffinger, Jennifer E. Liu, Richard M. Steingart
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
Jesus Jimenez, Nicolas Kostelecky, Joshua D. Mitchell, Kathleen W. Zhang, Chieh-Yu Lin, Daniel J. Lenihan, Kory J. Lavine
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression
Khan O. Mohammad, Hanna Fanous, Sneha Vakamudi, Yan Liu
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18F-FDG PET/CT as a new biomarker
Mônica M. C. Becker, Gustavo F. A. Arruda, Diego R. F. Berenguer, Roberto O. Buril, Daniela Cardinale, Simone C. S. Brandão
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study
Dae Hyun Lee, Sanjay Chandrasekhar, Michael D. Jain, Rahul Mhaskar, Kayla Reid, Sae Bom Lee, Salvatore Corallo, Melanie J. Hidalgo-Vargas, Abhishek Kumar, Julio Chavez, Bijal Shah, Aleksandr Lazaryan, Farhad Khimani, Taiga Nishihori, Christina Bachmeier, Rawan Faramand, Michael G. Fradley, Daniel Jeong, Guilherme H. Oliveira, Frederick L. Locke, Marco L Davila, Mohammed Alomar
Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer
Sarju Ganatra, Sonu Abraham, Ashish Kumar, Rohan Parikh, Rushin Patel, Sumanth Khadke, Amudha Kumar, Victor Liu, Andrea Nathalie Rosas Diaz, Tomas G. Neilan, David Martin, Bruce Hook, Sourbha S. Dani, Aarti Asnani, Anju Nohria
Detection of right ventricular dysfunction by three – dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy
Wafaa S. El-Sherbeny, Nesreen M. Sabry, Shaimaa B. El-Saied, Basma Elnagar
Effect of insulin resistance on CAC scores in cancer survivors
N. Jacobi, S. Ortman, L. Buda, Daniel Duprez
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Holden Eaton, Kerstin Nina Timm
Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis
Matthew Dean, Min Jung Kim, Sharon Dimauro, Susan Tannenbaum, Garth Graham, Bruce T. Liang, Agnes S. Kim
Quantitative assessment of radiotherapy-induced myocardial damage using MRI: a systematic review
Alireza Omidi, Elisabeth Weiss, Cory R. Trankle, Mihaela Rosu-Bubulac, John S. Wilson
The association of QTc prolongation with cardiovascular events in cancer patients taking tyrosine kinase inhibitors (TKIs)
Ismail Ghafary, Chang-Kyung Kim, Eric Roth, Michael Lu, Erin M. Taub, Susan Lee, Ira Cohen, Zhongju Lu
Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapy
Prince Otchere, Olusola Adekoya, Samuel B. Governor, Naveen Vuppuluri, Akruti Prabhakar, Stella Pak, Oduro Oppong-Nkrumah, Francis Cook, Rudy Bohinc, Gregory Aune
Mediastinal gray zone lymphoma in a pregnant woman presenting with cardiac tamponade
Azin Alizadehasl, Kamran Roudini, Mahshid Hesami, Farid kosari, Hamid Reza Pouraliakbar, Mina Mohseni, Negar Dokhani
Late-stage diagnosis of carcinoid heart disease due to lack of access to health care
Aditi Sharma, Maria E. Fierro, Stella Pak, Keerthi Thallapureddy, Moyosore Awobajo, Dawn Hui, Prince Otchere
Atrial fibrillation in cancer survivors – a systematic review and meta-analysis
Yueyang Bao, John Lee, Udit Thakur, Satish Ramkumar, Thomas H. Marwick
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Jeannette R. Wong-Siegel, Robert J. Hayashi, Randi Foraker, Joshua D. Mitchell
Simultaneous exercise stress cardiac magnetic resonance and cardiopulmonary exercise testing to elucidate the Fick components of aerobic exercise capacity: a feasibility and reproducibility study and pilot study in hematologic cancer survivors
Justin M. Canada, John McCarty, Jennifer H. Jordan, Cory R. Trankle, Kevin DeCamp, Josh D. West, Mary Ann Reynolds, Rachel Myers, Katey Sweat, Virginia McGhee, Ross Arena, Antonio Abbate, W. Gregory Hundley
Screening and management of dyslipidemia in oncologic patients undergoing cardiotoxic therapies: results from an Italian survey
Massimiliano Camilli, Irma Bisceglia, Maria Laura Canale, Fabio Maria Turazza, Leonardo De Luca, Domenico Gabrielli, Michele Massimo Gulizia, Fabrizio Oliva, Furio Colivicchi
Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience
Andrew W. Hahn, Whittney Thoman, Efstratios Koutroumpakis, Amer Abdulla, Sumit K. Subudhi, Ana Aparicio, Karen Basen-Enngquist, Christopher J. Logothetis, Susan C. Gilchrist
Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis
Michael P. O’Shea, Suganya Arunachalam Karikalan, Ali Yusuf, Timothy Barry, Eiad Habib, John O’Shea, Michael Killian, Eman Baqal, Srishti Nayak, Rajeev Masson, Joerg Hermann, Shimoli Shah, Chadi Ayoub, Hicham El Masry
Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: real-world evidence from a tertiary healthcare system
Abdulrazaq S. Al-Jazairi, Nahlah Bahammam, Dhai Aljuaid, Lama Almutairi, Shroog Alshahrani, Norah Albuhairan, Peter M. B. Cahusac, Ghazwa B. Korayem
Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2
Brijesh Patel, Scott A. Chapman, Jake T. Neumann, Aayush Visaria, Oluwabunmi Ogungbe, Sijin Wen, Maryam Khodaverdi, Priyal Makwana, Jasvinder A. Singh, George Sokos, Adam B. Wilcox, Adam M. Lee, Alexis Graves, Alfred Jerrod Anzalone, Amin Manna, Amit Saha, Amy Olex, Andrea Zhou, Andrew E. Williams, Andrew Southerland, Andrew T. Girvin, Anita Walden, Anjali A. Sharathkumar, Benjamin Amor, Benjamin Bates, Brian Hendricks, Caleb Alexander, Carolyn Bramante, Cavin Ward-Caviness, Charisse Madlock-Brown, Christine Suver, Christopher Chute, Christopher Dillon, Chunlei Wu, Clare Schmitt, Cliff Takemoto, Dan Housman, Davera Gabriel, David A. Eichmann, Diego Mazzotti, Don Brown, Eilis Boudreau, Elaine Hill, Elizabeth Zampino, Emily Carlson Marti, Emily R. Pfaff, Evan French, Farrukh M. Koraishy, Federico Mariona, Fred Prior, Greg Martin, Harold Lehmann, Heidi Spratt, Hemalkumar Mehta, Hongfang Liu, Hythem Sidky, J. W. Awori Hayanga, Jami Pincavitch, Jaylyn Clark, Jeremy Richard Harper, Jessica Islam, Jin Ge, Joel Gagnier, Joel H. Saltz, Joel Saltz, Johanna Loomba, John Buse, Jomol Mathew, Joni L. Rutter, Julie A. McMurry, Justin Guinney, Justin Starren, Karen Crowley, Katie Rebecca Bradwell, Kellie M. Walters, Ken Wilkins, Kenneth R. Gersing, Kenrick Dwain Cato, Kimberly Murray, Kristin Kostka, Lavance Northington, Lee Allan Pyles, Leonie Misquitta, Lesley Cottrell, Lili Portilla, Mariam Deacy, Mark M. Bissell, Marshall Clark, Mary Emmett, Mary Morrison Saltz, Matvey B. Palchuk, Melissa A. Haendel, Meredith Adams, Meredith Temple-O’Connor, Michael G. Kurilla, Michele Morris, Nabeel Qureshi, Nasia Safdar, Nicole Garbarini, Noha Sharafeldin, Ofer Sadan, Patricia A. Francis, Penny Wung Burgoon, Peter Robinson, Philip R. O. Payne, Rafael Fuentes, Randeep Jawa, Rebecca Erwin-Cohen, Rena Patel, Richard A. Moffitt, Richard L. Zhu, Rishi Kamaleswaran, Robert Hurley, Robert T. Miller, Saiju Pyarajan, Sam G. Michael, Samuel Bozzette, Sandeep Mallipattu, Satyanarayana Vedula, Shawn T. O’Neil, Soko Setoguchi, Stephanie S. Hong, Steve Johnson, Tellen D. Bennett, Tiffany Callahan, Umit Topaloglu, Usman Sheikh, Valery Gordon, Vignesh Subbian, Warren A. Kibbe, Wenndy Hernandez, Will Beasley, Will Cooper, William Hillegass, Xiaohan Tanner Zhang
Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology
Sherry-Ann Brown, Abdulaziz Hamid, Erin Pederson, Allen Hanna BS, Ragasnehith Maddula, Rachel Goodman, Morgan Lamberg, Pedro Caraballo, Peter Noseworthy, Opeoluwa Lukan, Gift Echefu, Generika Berman, Indrajit Choudhuri
Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report
Karishma Patel, Kristie Y. Hsu, Kevin Lou, Krishan Soni, Yoo Jin Lee, Claire K. Mulvey, Alan H. Baik
Utilization and short-term outcomes of percutaneous left atrial appendage occlusion in patients with cancer
Yaqi Zhang, Zhuoran Yang, Muhammad U. Almani, Raquel Soon-Shiong, Bolun Liu
Cardiac electrical abnormalities in childhood acute lymphoblastic leukemia survivors: a systematic review
Émilie Bertrand, Maxime Caru, Audrey Harvey, Philippe Dodin, Vincent Jacquemet, Daniel Curnier
Cardiovascular disease incidence rates: a study using routinely collected health data
Johanna Ramroth, Rebecca Shakir, Sarah C. Darby, David J. Cutter, Valerie Kuan
Surveillance cardiopulmonary exercise testing can risk-stratify childhood cancer survivors: underlying pathophysiology of poor exercise performance and possible room for improvement
Takeshi Tsuda, Kimberly Davidow, Gina D’Aloisio, Joanne Quillen
Correction: Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report
Karishma Patel, Kristie Y. Hsu, Kevin Lou, Krishan Soni, Yoo Jin Lee, Claire K. Mulvey, Alan H. Baik
The toxic tango: TKI and ICI cardiotoxicities
Juan Del Cid Fratti, Vijayasree Paleru, Madhuri Bajaj, Chetan Bhardwaj
Lessons learnt in the first year of an Australian pediatric cardio oncology clinic
Claudia Toro, Ben Felmingham, Mangesh Jhadav, David S. Celermajer, Andre La Gerche, John O’Sullivan, Sanjeev Kumar, Marion K. Mateos, Joy Fulbright, Dinisha Govender, Lane Collier, Michael Cheung, David D. Eisenstat, Peter W. Lange, Julian Ayer, David A. Elliott, Rachel Conyers
Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management
Amir Askarinejad, Azin Alizadehasl, Amir Ghaffari Jolfayi, Sara Adimi
14,15-Dihydroxyeicosatrienoic acid, a soluble epoxide hydrolase metabolite in blood, is a predictor of anthracycline-induced cardiotoxicity – a hypothesis generating study
Julia Matzenbacher dos Santos, Aby Joiakim, David A. Putt, Marielle Scherrer-Crosbie, Hyesook Kim